Home » Topics » BioWorld Science

BioWorld Science
RSS

Versican biomarker shown to be prognostic in patients with pancreatic neuroendocrine tumors

Jan. 31, 2018

Interim data from phase I/II trial of LiPlaCis in heavily pretreated breast cancer

Jan. 31, 2018

Eisai and Boston University enter Alzheimer's research collaboration

Jan. 31, 2018

EMA committee recommends approval of biosimilar insulin glargine Semglee

Jan. 31, 2018

FDA places U.S. studies of BPX-501 on clinical hold

Jan. 31, 2018

Aravive Biologics and WuXi Biologics to expand collaboration following IND filing for AVB-S6-500

Jan. 31, 2018

Shire acquires license to AB Biosciences' PRIM program

Jan. 31, 2018

EMA committee recommends approval of use of Ameluz with daylight PDT

Jan. 31, 2018

Rexgenero receives ATMP certificate from EMA for REX-001

Jan. 31, 2018

BiomX licenses bacterial targets for IBD

Jan. 31, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...